Picard Medical, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
The Fundamentalytics view
Current signal Results well short of expectations: Reported earnings per share missed the analysts' consensus estimate by 103% in the quarter to 2026-06-30.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Highlights
How we pick theseStrengths
Nothing in Picard Medical, Inc.'s latest figures clears our strength thresholds.
Things to watch
- Volatile shares. Over the past year the shares showed annualised volatility of 223% and a beta of 1.6 against the S&P 500.
Latest results
- Earnings per share
- -$3.05 against an average estimate of -$1.50: missed by 103.3%
- Share reaction
- -1.9% in the first session after the results on May 21, 2026, against +0.6% for the S&P 500
- Next report
- August 14, 2026; average EPS estimate -$1.50
Price chart
- 1 day-11.7%
- 1 week+10.9%
- 1 month+31.1%
- This year-90.2%
- 1 year-94.8%
- S&P 500 this year+11.2%
Loading chart…
Third-party market data · may be delayed
At a glance
Earnings
- Last results
- May 21, 2026
News & updates
Company announcements, filed results and changes that matter to shareholders.
- AgreementSEC 8-KRead source ↗
- Governance
Picard Medical, Inc. amended its charter or bylaws
SEC 8-KRead source ↗ - Financing
Picard Medical, Inc. took on a material financial obligation; sold unregistered shares
SEC 8-KRead source ↗ - Announcement
Picard Medical, Inc. made a public disclosure
SEC 8-KRead source ↗ - Announcement
Picard Medical, Inc. disclosed a material event
SEC 8-KRead source ↗ - Announcement
Picard Medical, Inc. amended its charter or bylaws; disclosed a material event
SEC 8-KRead source ↗ - Shareholder vote
Picard Medical, Inc. reported shareholder vote results
SEC 8-KRead source ↗
No model value for Picard Medical, Inc. at the moment. Current status: limited reported history: available models are shown without a Buy/Hold/Sell rating. Available reported financials are shown below.
Valuation models
We value Picard Medical, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: revenue and margins don't support a positive value |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | — | Does not apply: no twelve-month earnings or share count in the filings yet |
| Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | — | No model applies: the filings don’t yet support a value. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Picard Medical, Inc. with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Forecasts and guidance
Analysts' consensus
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | −$8.50 | +77% | $6m | — |
| Next | −$4.50 | — | $6m | +7% |
Earnings against estimates
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | −$1.50 | −$3.05 | −103.3% |
Adjusted EPS as companies report it, against the average analyst estimate.
Positioning
- Short interest
- 3.3% of tradable shares
- Days to cover
- 0.13 at average volume
- Short interest, 1 month
- −78% to October 15, 2026
- Held by institutions
- 6% of shares
- Held by insiders
- 41.9% of shares
- Employees
- 75 full time
Share-price performance
Market data may be delayedReturn and risk by year
| Calendar year | 2026 to date |
|---|---|
| Return | |
| PMI | −90% |
| Industry peers (median) | −13% |
| S&P 500 | +11% |
| Months that ended higher | |
| PMI | 36% |
| S&P 500 | 46% |
| Largest fall from a high during the year | |
| PMI | −97% |
| S&P 500 | −9% |
Worst fall since August 29, 2025: 100% from October 23, 2025 to August 20, 2026. Getting back needed a 21682% gain, and the shares have not yet recovered.
Price behaviour
- 52-week range
- $3.03 – $184.50
- From 52-week high
- −95.3%
- vs 50-day average
- +17.7%
- vs 200-day average
- −68.4%
- Volatility (1 year)
- 223%
- Beta vs S&P 500
- 1.56
Share price after results
- Next day
- 2 up, 2 down typical move ±2.8%
- After a week
- 1 up, 3 down typical move ±15.3%
- After a month
- 1 up, 3 down typical move ±29.2%
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| May 21, 2026 | −1.9% | +0.6% | −3.9% | +13.0% |
| April 22, 2026 | −0.8% | +0.6% | −44.2% | −83.4% |
| March 25, 2026 | +2.0% | −1.2% | +6.1% | −14.5% |
| November 14, 2025 | +6.6% | −0.9% | −7.0% | −5.7% |
Fundamentals
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products | $4.7M | 96.1% | ▲ 11.6% |
| Rentals | $194,000 | 3.9% | ▲ 41.6% |
From Picard Medical, Inc.'s 10-K filed March 30, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Insider trading activity
Full insider history and chartFrom insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Earnings dates and SEC filings
Results announcements
- May 21, 2026
- April 22, 2026
- March 25, 2026
- November 14, 2025
Recent SEC filings
- 8-K Current report
- S-3 FORM S-3
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
Data status
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
Picard Medical, Inc. in brief
- What does Picard Medical, Inc. do?
- Picard Medical, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
- What is Picard Medical, Inc.'s stock ticker?
- Picard Medical, Inc. trades under the ticker PMI on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
Follow research on Picard Medical, Inc.
New research on the companies we cover arrives in the weekly email. Free, one email a week.